These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 21561706)

  • 41. Prioritization of chemicals in the aquatic environment based on risk assessment: analytical, modeling and regulatory perspective.
    Guillén D; Ginebreda A; Farré M; Darbra RM; Petrovic M; Gros M; Barceló D
    Sci Total Environ; 2012 Dec; 440():236-52. PubMed ID: 22809786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implications of chemical mixtures in public health practice.
    de Rosa CT; El-Masri HA; Pohl H; Cibulas W; Mumtaz MM
    J Toxicol Environ Health B Crit Rev; 2004; 7(5):339-50. PubMed ID: 15371239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modeling exposure to persistent chemicals in hazard and risk assessment.
    Cowan-Ellsberry CE; McLachlan MS; Arnot JA; Macleod M; McKone TE; Wania F
    Integr Environ Assess Manag; 2009 Oct; 5(4):662-79. PubMed ID: 19552503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A framework for assessing the impact of land use policy on community exposure to air toxics.
    Willis MR; Keller AA
    J Environ Manage; 2007 Apr; 83(2):213-27. PubMed ID: 16842900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human toxicity potentials for life-cycle assessment and toxics release inventory risk screening.
    Hertwich EG; Mateles SF; Pease WS; McKone TE
    Environ Toxicol Chem; 2001 Apr; 20(4):928-39. PubMed ID: 11345472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exposure information in environmental health research: current opportunities and future directions for particulate matter, ozone, and toxic air pollutants.
    McKone TE; Ryan PB; Ozkaynak H
    J Expo Sci Environ Epidemiol; 2009 Jan; 19(1):30-44. PubMed ID: 18385670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The ToxCast program for prioritizing toxicity testing of environmental chemicals.
    Dix DJ; Houck KA; Martin MT; Richard AM; Setzer RW; Kavlock RJ
    Toxicol Sci; 2007 Jan; 95(1):5-12. PubMed ID: 16963515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Application of an integrated testing strategy to the U.S. EPA endocrine disruptor screening program.
    Willett CE; Bishop PL; Sullivan KM
    Toxicol Sci; 2011 Sep; 123(1):15-25. PubMed ID: 21642633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrating site-specific dispersion modeling into life cycle assessment, with a focus on inhalation risks in chemical production.
    Tian S; Bilec M
    J Air Waste Manag Assoc; 2018 Nov; 68(11):1224-1238. PubMed ID: 29985784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. It is time for changes in the analysis of whole effluent toxicity data.
    Diamond J; Denton D; Anderson B; Phillips B
    Integr Environ Assess Manag; 2012 Apr; 8(2):351-8. PubMed ID: 21919188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modeling pharmaceutical emissions and their toxicity-related effects in life cycle assessment (LCA): A review.
    Emara Y; Lehmann A; Siegert MW; Finkbeiner M
    Integr Environ Assess Manag; 2019 Jan; 15(1):6-18. PubMed ID: 30242966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carcinogenic Air Toxics Exposure and Their Cancer-Related Health Impacts in the United States.
    Zhou Y; Li C; Huijbregts MA; Mumtaz MM
    PLoS One; 2015; 10(10):e0140013. PubMed ID: 26444872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of different life-cycle impact assessment methods for aquatic ecotoxicity.
    Schulze C; Jödicke A; Scheringer M; Margni M; Jolliet O; Hungerbühler K; Matthies M
    Environ Toxicol Chem; 2001 Sep; 20(9):2122-32. PubMed ID: 11521844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identifying inequitable exposure to toxic air pollution in racialized and low-income neighbourhoods to support pollution prevention.
    Kershaw S; Gower S; Rinner C; Campbell M
    Geospat Health; 2013 May; 7(2):265-78. PubMed ID: 23733289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ecological risk assessment of urban and industrial systems: a review.
    Perrodin Y; Boillot C; Angerville R; Donguy G; Emmanuel E
    Sci Total Environ; 2011 Nov; 409(24):5162-76. PubMed ID: 21944201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. International harmonization of models for selecting less toxic chemical alternatives: Effect of regulatory disparities in the United States and Europe.
    Lam CW; Aguirre MP; Schischke K; Nissen NF; Ogunseitan OA; Schoenung JM
    Integr Environ Assess Manag; 2012 Oct; 8(4):723-30. PubMed ID: 22492719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use and acceptance of Other Scientifically Relevant Information (OSRI) in the U.S. Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program.
    Bishop PL; Willett CE
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):3-22. PubMed ID: 24151143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An independent review and prioritization of past radionuclide and chemical releases from the Los Alamos National Laboratory--implications for future dose reconstruction studies.
    Le MH; Buddenbaum JE; Burns RE; Shonka JJ; Gaffney SH; Donovan EP; Flack SM; Widner TE
    J Environ Monit; 2011 Oct; 13(10):2735-47. PubMed ID: 21904770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and modelling approaches to risk assessment from the U.S. Environmental Protection Agency ToxCast programme.
    Judson R; Houck K; Martin M; Knudsen T; Thomas RS; Sipes N; Shah I; Wambaugh J; Crofton K
    Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):69-76. PubMed ID: 24684691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.